Clinical Trials
3 trialsNCT03924986 2025-01-31
RATIONALE-309
BeiGene
Phase 3 Completed
NCT02611960 2023-07-13
Keynote-122
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT00603915 2019-02-28
A Study of Gemcitabine and Cisplatin/Carboplatin Plus Erlotinib in Patients With Nasopharyngeal Cancer
University Health Network, Toronto
Phase 2 Completed